Hydroxyurea therapy in E-β-thalassemia:: Effect on hemoglobin and on RBC characteristics.

被引:0
|
作者
Singer, ST
Kuypers, F
Mignacca, R
Kennedy, N
Olivieri, N
Weatherall, D
Vichinsky, E
机构
[1] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA
[2] Valley Childrens Hosp, Fresno, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1878
引用
收藏
页码:424A / 424A
页数:1
相关论文
共 48 条
  • [41] Effect of Tumor Necrosis Factor-Alpha on Erythropoietin-and Erythropoietin Receptor-Induced Erythroid Progenitor Cell Proliferation in β-Thalassemia/Hemoglobin E Patients
    Tanyong, Dalina I.
    Panichob, Prapaporn
    Kheansaard, Wasinee
    Fucharoen, Suthat
    TURKISH JOURNAL OF HEMATOLOGY, 2015, 32 (04) : 304 - 310
  • [42] EFFECT OF DIALYSIS THERAPY ON THE T, EAC+ AND E- EAC- LYMPHOCYTE COUNTS .2. ACUTE RENAL-FAILURE
    ZUKOWSKASZCZECHOWSKA, E
    ACTA MEDICA POLONA, 1984, 25 (1-4) : 63 - 71
  • [43] EFFECT OF DIALYSIS THERAPY ON THE T, EAC+ AND E- EAC- LYMPHOCYTE COUNTS .1. CHRONIC RENAL-FAILURE
    ZUKOWSKASZCZECHOWSKA, E
    ACTA MEDICA POLONA, 1984, 25 (1-4) : 45 - 62
  • [44] Effect of iron therapy on red cell indices and hemoglobin subtypes on patients with beta-thalassemia trait who developed iron-deficiency anemia: a tertiary center experience
    Sawsan M. Moeen
    Ahmad F. Thabet
    Marwa M. Thabet
    The Egyptian Journal of Internal Medicine, 2019, 31 (4) : 741 - 745
  • [45] Effect of Luspatercept on Red Blood Cell (RBC) Transfusion Burden, Iron Chelation Therapy (ICT), and Iron Overload in Adults with Transfusion-Dependent ß-Thalassemia (TDT) from the BELIEVE Trial: A Long-Term Analysis
    Hermine, Olivier
    Cappellini, Maria Domenica Domenica
    Taher, Ali T.
    Coates, Thomas D.
    Viprakasit, Vip
    Kattamis, Antonis
    Shetty, Jeevan K.
    Weisskopf, Marija Bosilkovska
    Holot, Natalia
    Vodala, Sadanand
    Kuo, Wen-Ling
    Porter, John B.
    BLOOD, 2022, 140 : 8215 - 8217
  • [46] A Randomized Prospective Study to Assess the Effect of Vitamin E on Peroxiredoxin-2 As a Novel Antioxidant Marker in Young Beta-Thalassemia Major Patients on Different Chelation Therapy
    Abd el Mohsen, Mohamed
    Saber, Maha
    Adly, Amira
    Ismail, Eman
    Elalfy, Omar
    Islam, Elghamry
    Ibrahim, Fatma
    Elalfy, Mohsen Saleh
    BLOOD, 2018, 132
  • [47] Hemoglobin profile and molecular characteristics of the complex interaction of hemoglobin Doi-Saket [α9(A7) asn > lys, HBA2:c.30C > a], a novel α2α1 hybrid globin variant, with hemoglobin E [β26(B8) Glu > lys, HBB:c.79G > A] and deletional α+-thalassemia in a Thai family
    Panyasai, Sitthichai
    Khongthai, Kunyakan
    Satthakarn, Surada
    ANNALS OF MEDICINE, 2023, 55 (02)
  • [48] Clinical characteristics, laboratory features and genetic profile of hemoglobin E (HBB:c.79 G > A)/(3 (nucleotide-28 A> G) (HBB:c.-78 A> G) -thalassemia subjects identified from community- and hospital-recruited cohorts
    Chumnumsiriwath, Piyatida
    Charoenporn, Prissana
    Jermnim, Sawichayaporn
    Suannum, Pawanrat
    Samaisombat, Monthira
    Tapprom, Akamon
    Deoisares, Rawisut
    Wong, Peerapon
    BLOOD CELLS MOLECULES AND DISEASES, 2024, 109